Short communication · 18 Jun 2021
Conference abstractPublished 29 Oct 2012
How mycobacteria modulate immune responses in host
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
O ne third of the world?s population is infected by Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), yet only few develop into active disease. This is due to the ability of this bacterium to be latent in its host by altering the immune response by its cell wall components, Lipoarabinomannan (LAM) and lipomannan (LM). During an infection, these complex molecules are recognized by Toll-like receptors (TLRs), however, little is known about the functional outcomes of such interactions. A detailed structural/functional study requires structural variants of these lipoglycans, however, limitation in generating M. tuberculosis mutants with variant molecules is restricting such studies. In this regard, Corynebacterium glutamicum represents an attractive model, as it has been demonstrated to tolerate mutations in essential cell wall components. Using a genetically engineered C. glutamicum, we purified a hypermannosylated form of LM, hLM, and compared its structural/ functional immunological activity to that of the wild-type LAM. Interestingly, the extent of arabinan branching modulated the innate immune response via TLR2, with a previously unknown impact on T helper cell differentiation. Our data sheds further light on modulation of innate and acquired immune responses through the modulation of the interaction of TLR2 with specific chemical entities. Furthermore, our study supports the potential of specific lipoglycan structures as novel vaccine adjuvants against TB
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2021
The Immune Responses and Its Therapeutic Modulation in a chronic pulmonary diseases
Editorial · 11 Apr 2024
Mycobacterial Nucleic Acids Modulate Host Innate Immune Responses
Review article · 21 Jun 2023
Toxoplasma gondii Exosomes: Versatile Tools for Understanding Host-Parasite Interactions, Developing Therapeutics, and Modulating Host Immune Responses and Metabolism
Review article · 16 Nov 2017
Modulation of host immune response by human papillomaviruses and role of E6/E7 oncoproteins in development of cervical precursor lesions and cervical cancer.
More from this journal
The newest in Pulmonary & Respiratory Medicine.
Article · 9 Feb 2026
Magnitude and Associated Factors of Respiratory Distress Syndrome among Preterm Neonate Admitted to Addis Ababa Public Hospital, Ethiopia 2023/24
Commentary · 29 Dec 2025
Evolving IPF: Personalized Therapies, Future Directions
Brief report · 29 Dec 2025
PH/PAH: Advancements, Guidelines, Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPulmonary & Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Arun Kumar Mishra”

